Development and Content Validation of Novel Patient-Reported Outcome Measures to Assess Disease Severity and Change in Patients with Erythropoietic Protoporphyria: The EPP Impact Questionnaire (EPIQ)
Patient Related Outcome Measures · 2024-02 · Volume 15 · 17-30
DOI: 10.2147/prom.s438892 ↗Kurz gefasst
Fachartikel in der Zeitschrift Patient Related Outcome Measures, 2024-02. Verfasst von Susan D Mathias und 5 weiteren Autor:innen. Beteiligte Einrichtung: Health Outcomes Solutions, Palm Beach Gardens, FL, USA. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Health Outcomes Solutions, Palm Beach Gardens, FL, USA.
- LORA Group, Normal, IL, USA.
- Disc Medicine, Watertown, MA, USA.
- Department of Genetics, Stanford University School of Medicine, Palo Alto, CA, USA.
ORCID-Profile: Hetanshi Naik
Zitieren
APA
Mathias, S. D., Burke, L., Colwell, H. H., Mensing, G., Savage, W., & Naik, H. (2024). Development and Content Validation of Novel Patient-Reported Outcome Measures to Assess Disease Severity and Change in Patients with Erythropoietic Protoporphyria: The EPP Impact Questionnaire (EPIQ). Patient Related Outcome Measures, Volume 15, 17-30. https://doi.org/10.2147/prom.s438892
Vancouver
Mathias SD, Burke L, Colwell HH, Mensing G, Savage W, Naik H. Development and Content Validation of Novel Patient-Reported Outcome Measures to Assess Disease Severity and Change in Patients with Erythropoietic Protoporphyria: The EPP Impact Questionnaire (EPIQ). Patient Related Outcome Measures. 2024;Volume 15:17-30. doi:10.2147/prom.s438892
BibTeX
@article{Mathias2024,
author = {Mathias, Susan D and Burke, Laurie and Colwell, Hilary H and Mensing, George and Savage, Will and Naik, Hetanshi},
title = {Development and Content Validation of Novel Patient-Reported Outcome Measures to Assess Disease Severity and Change in Patients with Erythropoietic Protoporphyria: The EPP Impact Questionnaire (EPIQ)},
journal = {Patient Related Outcome Measures},
year = {2024},
volume = {Volume 15},
pages = {17--30},
doi = {10.2147/prom.s438892}
}
EUVIMED